Haruhito Sugiyama Selected Research

Haruhito Sugiyama Research Topics

Disease

18	Asthma (Bronchial Asthma) 01/2022 - 07/2010
12	Rheumatoid Arthritis 01/2021 - 09/2007
11	COVID-19 07/2022 - 06/2020
10	Pneumonia (Pneumonitis) 06/2021 - 01/2006
7	Neoplasms (Cancer) 01/2022 - 01/2006
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2009
6	Inflammation (Inflammations) 10/2020 - 01/2013
5	Adenocarcinoma of Lung 01/2022 - 08/2009
5	Infections 04/2021 - 01/2012
5	Lung Neoplasms (Lung Cancer) 10/2020 - 02/2011
5	Tuberculosis (Tuberculoses) 03/2018 - 12/2006
4	Hemoptysis 10/2022 - 05/2009
4	Pleural Tuberculosis 03/2022 - 08/2013
4	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 02/2011
4	Pleural Effusion (Pleural Effusions) 01/2021 - 10/2007
4	Lung Diseases (Lung Disease) 01/2020 - 03/2008
4	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 11/2013 - 03/2009
3	Granuloma 08/2020 - 09/2013
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 01/2006
3	Yellow Nail Syndrome 08/2018 - 09/2011
3	Chronic Obstructive Pulmonary Disease (COPD) 09/2017 - 01/2012
3	Cough 09/2013 - 10/2007
2	Arthralgia (Joint Pain) 01/2022 - 03/2008
2	Edema (Dropsy) 01/2022 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2014
2	Pulmonary Alveolar Proteinosis 01/2020 - 01/2019
2	Lymphoma (Lymphomas) 03/2014 - 09/2007
2	Communicable Diseases (Infectious Diseases) 12/2013 - 03/2009
2	Fever (Fevers) 09/2013 - 10/2007
2	Opportunistic Infections (Opportunistic Infection) 11/2012 - 11/2012
1	False Aneurysm (Pseudoaneurysm) 10/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2022
1	Persistent Infection 07/2022
1	Pseudomonas Infections 01/2022
1	Breakthrough Infections 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Obesity 01/2022
1	Atrial Fibrillation 01/2021

Drug/Important Bio-Agent (IBA)

8	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 01/2006
7	SteroidsIBA 01/2022 - 07/2010
6	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 10/2007
4	ErbB Receptors (EGF Receptor)IBA 10/2020 - 08/2009
4	Methotrexate (Mexate)FDA LinkGeneric 11/2012 - 09/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 09/2011
3	CytokinesIBA 01/2021 - 07/2014
3	Pharmaceutical PreparationsIBA 12/2020 - 10/2008
3	pembrolizumabIBA 03/2020 - 01/2020
3	Clarithromycin (Biaxin)FDA LinkGeneric 08/2018 - 09/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 11/2012
3	Infliximab (Remicade)FDA Link 01/2017 - 03/2009
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 01/2013
2	Hemostatics (Antihemorrhagics)IBA 10/2022 - 03/2019
2	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 10/2022 - 09/2011
2	Rituximab (Mabthera)FDA Link 07/2022 - 03/2014
2	Adenosine DeaminaseIBA 03/2022 - 01/2020
2	VaccinesIBA 01/2022 - 01/2022
2	Immunoglobulin G (IgG)IBA 10/2021 - 01/2020
2	Polymyxin B (Aerosporin)FDA LinkGeneric 06/2021 - 10/2020
2	Therapeutic UsesIBA 06/2021 - 10/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2020 - 12/2016
2	Tyrosine Kinase InhibitorsIBA 10/2020 - 08/2009
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 01/2019
2	PlatinumIBA 01/2019 - 12/2016
2	Immunoglobulin E (IgE)IBA 01/2015 - 08/2013
2	Adalimumab (Humira)FDA Link 11/2013 - 09/2013
2	Salmeterol Xinafoate (Serevent)FDA Link 03/2013 - 01/2013
2	Fluticasone (Cutivate)FDA LinkGeneric 03/2013 - 01/2013
2	Budesonide (Pulmicort)FDA LinkGeneric 03/2013 - 01/2013
2	Formoterol Fumarate (Oxis)FDA Link 03/2013 - 01/2013
2	Etanercept (Enbrel)FDA Link 11/2012 - 11/2012
2	Gefitinib (Iressa)FDA Link 10/2012 - 08/2009
2	Carboplatin (JM8)FDA LinkGeneric 11/2011 - 02/2011
2	Antirheumatic Agents (DMARD)IBA 08/2011 - 03/2008
1	Docetaxel (Taxotere)FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	taxaneIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	CreatinineIBA 01/2022
1	Bronchodilator Agents (Bronchodilators)IBA 01/2022
1	AntigensIBA 07/2021
1	Polystyrenes (Polystyrene)IBA 06/2021
1	Antiviral Agents (Antivirals)IBA 04/2021
1	Serine Proteases (Serine Protease)IBA 04/2021
1	Angiotensin-Converting Enzyme 2IBA 04/2021
1	remdesivirIBA 04/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021

Therapy/Procedure

20	Therapeutics 10/2022 - 12/2006
9	Bronchial Thermoplasty 01/2022 - 07/2017
8	Drug Therapy (Chemotherapy) 01/2019 - 02/2007
3	Surgical Instruments (Clip) 01/2021 - 07/2020
3	Local Anesthesia 01/2020 - 08/2013
3	Aftercare (After-Treatment) 02/2018 - 09/2011
2	Hemoperfusion 06/2021 - 10/2020
2	Artificial Respiration (Mechanical Ventilation) 10/2020 - 06/2020
2	Nebulizers and Vaporizers (Inhaler) 03/2013 - 01/2013
1	Conservative Treatment 10/2022